ANNOUNCEMENT 15 Jun 2020

June 15th, 2020 - The Japanese government announced an tightening of its policy on inward FDI.

NUMBER OF INTERVENTIONS

1

  • 1 harmful
  • 0 neutral
  • 0 liberalising

SOURCE

Japan Ministry for Economy, Trade and Industry, June 15th, 2020. (Addition of Pharmaceutical and Special Medical Device Manufacturing businesses, to Core Designated Business Sectors Subject to Inward Direct Investment Screening)
https://www.meti.go.jp/english/press/2020/0615_001.html

Inception date: 15 Jun 2020 | Removal date: open ended

FDI: Entry and ownership rule

On June 15th, 2020, the Japanese government announced it would be adding several types of firm to its list of 'core-designated businesses' - foreign investments in which of 1% or more (for listed companies) or anything at all are subject to a case-by-case government approval process before being allowed.

The new sectors added 'Class III' and 'Class IV' medical devices (including ventilators and extracorporeal membrane oxygenation machines), and pharmaceutical firms manufacturing treatments for infectious diseases, including precursor chemicals specifically used for such treatments.

For more information on the restrictions on investments in 'core-designated businesses' in Japan, please refer to the related state act.

HS codes included in this taxonomy are generated using a list of medical-related products and their corresponding codes released by the WTO.

AFFECTED SECTORS

 
N/A